2719.85 14.65 (0.54%)
4,886 NSE+BSE Volume
NSE Jul 01, 2022 03:31 PM
See past and forthcoming board meetings of AstraZeneca Pharma India Ltd. - ASTRAZEN, 506820
| Ex-date | Purpose | Notes |
|---|---|---|
| 2022-05-26 | Audited Results & Final Dividend | |
| 2022-02-08 | Quarterly Results | |
| 2021-11-09 | Quarterly Results | |
| 2021-08-09 | Quarterly Results & Interim Dividend | |
| 2021-05-25 | Audited Results | |
| 2021-02-08 | Quarterly Results | |
| 2020-11-05 | Quarterly Results | |
| 2020-08-10 | Quarterly Results & Interim Dividend | |
| 2020-05-18 | Audited Results | |
| 2020-02-03 | Quarterly Results | |
| 2019-11-11 | Quarterly Results | |
| 2019-08-07 | Quarterly Results & Interim Dividend | |
| 2019-05-24 | Audited Results | |
| 2019-02-06 | Quarterly Results | |
| 2018-11-13 | Quarterly Results | |
| 2018-08-13 | Unaudited Financial Results | |
| 2018-05-21 | Audited Results | |
| 2018-02-05 | Quarterly Results | |
| 2017-11-06 | Quarterly Results | |
| 2017-08-08 | Quarterly Results | |
| 2017-05-09 | Audited Results | |
| 2017-02-02 | Quarterly Results | |
| 2016-12-02 | Others | Mr. Rajesh Marwaha, Chief Financial Officer of the Company hasbeen inducted into the board as Additional and Whole-time Director. His profile is attached. |
| 2016-11-11 | Quarterly Results | |
| 2016-08-09 | Quarterly Results | |
| 2016-05-25 | Audited Results | |
| 2016-02-06 | Quarterly Results & Others | The Board of Directors approved the re-appointment of Mr. Sanjay Murdeshwar as Managing Director of the Company for a period of 3 years, to be effective from May 02, 2016. |
| 2015-12-02 | Others | Decided to close the Active Pharmaceutical Ingredient Unit (API Unit) situated at 12th Mile on Bellary Road,Venkatala, Yelahanka, Bangalore - 560063. |
| 2015-11-06 | Quarterly Results & Others | The Board appointed Ms. Claire-Marie O' Grady as Director of the Company in the vacancy caused by the resignation of Ms. Rebekah Martin with immediate effect. |
| 2015-08-04 | Quarterly Results | |
| 2015-05-27 | Audited Results | |
| 2015-02-11 | Quarterly Results | |
| 2014-11-03 | Quarterly Results | |
| 2014-08-12 | Quarterly Results | |
| 2014-05-30 | Audited Results | |
| 2014-05-05 | Others | To consider seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden,Promoter of the company. |
| 2014-04-15 | Others | To consider for the voluntary delisting proposed by AstraZeneca Pharmaceuticals Promoter of the Company, in terms of Securities and Exchange Board of India, through Postal Ballot. |
| 2014-03-15 | Others | To consider the voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden in terms of their letter dated March 01, 2014 at the meeting of the BOD of the Company held on March 15,2014. |
| 2014-03-05 | Others | |
| 2014-02-10 | Quarterly Results | |
| 2013-11-11 | Quarterly Results | |
| 2013-08-13 | Quarterly Results | |
| 2013-05-21 | Audited Results | |
| 2013-05-06 | Others | |
| 2013-05-02 | Quarterly Results | |
| 2013-02-06 | Quarterly Results | |
| 2012-11-07 | Quarterly Results | |
| 2012-08-10 | Quarterly Results | |
| 2012-05-11 | Audited & Quarterly Results | |
| 2012-02-02 | Quarterly Results | |
| 2011-11-10 | Quarterly Results | |
| 2011-08-08 | Quarterly Results | |
| 2011-06-14 | Others | inter alia, to consider and approve the proposal of straightening of land boundaries of factory with IDL Industries Ltd. |
| 2011-05-13 | Audited Results & Dividend | Fifteen Months. |
| 2011-02-08 | Quarterly Results | |
| 2010-10-27 | Quarterly Results | |
| 2010-07-27 | Quarterly Results & Others | For seeking the consent / approval of the Shareholders of the Company through postal ballot to the delisting proposal initiated by AstraZeneca Pharmaceuticals, AB, Sweden, promoter of the Company. |
| 2010-07-09 | Others | The Board has deferred the decision on delisting proposal initiated by AstraZeneca Pharmaceuticals AB Sweden, promoter of the Company. |
| 2010-06-29 | Voluntary Delisting of Shares | To make a voluntary delisting offer to the public Shareholders of the Co. in accordance with the SEBI (DES) Regulations, 2009 with a view to delist the Equity Shares from BSE, NSE & BgSE. |
| 2010-04-27 | Others | The Board has appointed Ms. Anita Zutshi as the Chief Financial Officer of the Company. |
| 2010-04-26 | Quarterly Results | |
| 2010-03-25 | Others | 1. Proposal to augment the Co's Tablet manufacturing plant and facility involving an estimated aggregate outlay of Rs. 70 Crs. 2. Appointment of Mr. Luigi Felice La Corte, as an Additional Director. |
| 2010-02-23 | Audited Results, Dividend & Others | The Board has approved the change in the accounting year of the Company from "January-December" to "April-March" & Recommended a Dividend of Rs. 10/- per Equity Share of face value of Rs. 2/- each. |
| 2009-10-27 | Quarterly Results | |
| 2009-07-27 | Quarterly Results | |
| 2009-04-23 | Quarterly Results | |
| 2009-02-18 | Audited Results & Dividend | |
| 2008-10-23 | Quarterly Results | |
| 2008-07-29 | Quarterly Results | |
| 2008-04-28 | Quarterly Results | |
| 2008-02-25 | Audited Results & Dividend | |
| 2007-10-26 | Quarterly Results | |
| 2007-07-26 | Quarterly Results | |
| 2007-04-30 | Quarterly Results | |
| 2007-03-17 | Interim Dividend | To consider the approval of the revised Audited Accounts for the financial year ended December 31, 2006, after incorporating necessary changes as to the revocation of recommended dividend & others. |
| 2007-02-23 | Accounts & Dividend | |
| 2006-10-28 | Quarterly Results | |
| 2006-09-08 | Issue of fully paid bonus debentures | Inter alia, to consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders |
| 2006-08-28 | Issue of fully paid bonus debentures | To consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders. (deferred) |
| 2006-07-28 | Quarterly Results | |
| 2006-05-09 | Sub Division of Equity shares | |
| 2006-04-29 | Quarterly Results | |
| 2006-02-23 | Accounts & Dividend | |
| 2005-10-20 | Quarterly Results | (Revised) |
| 2005-08-24 | Accounts | |
| 2005-04-27 | Quarterly Results | |
| 2005-02-16 | Accounts & Dividend | (Revised) |
| 2004-10-30 | Quarterly Results | |
| 2004-08-16 | Quarterly Results | |
| 2004-05-31 | Quarterly Results | (Revised) |
| 2004-04-21 | Others | Mr. Bhasker V. Iyer was appinted as an additional Director and Managing Director w.e.f. 06-05-2004. |
| 2004-03-04 | Others | Astra Pharmaceuticals AB(APAB) a promoter of the company, held 56.50% of the voting share capital of the company in March, 2002. |
| 2004-02-24 | Dividend & Accounts | |
| 2003-11-26 | Quarterly Results | |
| 2003-08-26 | Quarterly Results | |
| 2003-04-28 | Quarterly Results | |
| 2003-02-27 | Dividend, Accounts & Quarterly Results | |
| 2002-10-29 | Quarterly Results | |
| 2002-05-28 | Quarterly Results | |
| 2002-03-14 | Accounts & Dividend (9 months) |
Compare Stocks
